Skip to content

Drug interactions

Duvelisib + Tolterodine

Severity: Moderate

Duvelisib and Tolterodine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Duvelisib inhibits CYP3A4 and can raise exposure to CYP3A substrates. Tolterodine is mainly cleared via CYP2D6, but in CYP2D6 poor metabolizers CYP3A4 is the main route, so levels and anticholinergic effects could rise and the QT effect of tolterodine may matter.

What this interaction means in plain words

Duvelisib and Tolterodine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Duvelisib belongs to Oncology; Tolterodine belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated tolterodine metabolism by duvelisib.

What to do

Monitor for anticholinergic adverse effects and consider reducing the tolterodine dose, particularly in known CYP2D6 poor metabolizers.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duvelisib and Tolterodine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Duvelisib with Tolterodine?

MediHelp rates the interaction as moderate. Duvelisib and Tolterodine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Duvelisib inhibits CYP3A4 and can raise exposure to CYP3A substrates. Tolterodine is mainly cleared via CYP2D6, but in CYP2D6 poor metabolizers CYP3A4 is the main route, so levels and anticholinergic effects could rise and the QT effect of tolterodine may matter.

How serious is the interaction between Duvelisib and Tolterodine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic adverse effects and consider reducing the tolterodine dose, particularly in known CYP2D6 poor metabolizers.

What other medicines interact with Tolterodine?

MediHelp also lists interactions of Tolterodine with, for example, Clarithromycin, Clozapine, Cobicistat. The full list is on the Tolterodine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in